nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—Nephrosis lower nephron—Cyclosporine—rheumatoid arthritis	0.0724	0.115	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—NFATC1—rheumatoid arthritis	0.0342	0.682	CrCbGaD
Phenylpropanolamine—Renal tubular necrosis—Cyclosporine—rheumatoid arthritis	0.0213	0.0337	CcSEcCtD
Phenylpropanolamine—Liver injury—Azathioprine—rheumatoid arthritis	0.0124	0.0196	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—IL2—rheumatoid arthritis	0.0119	0.237	CrCbGaD
Phenylpropanolamine—Liver injury—Leflunomide—rheumatoid arthritis	0.0117	0.0185	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Azathioprine—rheumatoid arthritis	0.0104	0.0165	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Leflunomide—rheumatoid arthritis	0.00985	0.0156	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Leflunomide—rheumatoid arthritis	0.00985	0.0156	CcSEcCtD
Phenylpropanolamine—Liver injury—Cyclosporine—rheumatoid arthritis	0.00903	0.0143	CcSEcCtD
Phenylpropanolamine—Constipation—Ergocalciferol—rheumatoid arthritis	0.00812	0.0129	CcSEcCtD
Phenylpropanolamine—Agitation—Penicillamine—rheumatoid arthritis	0.00805	0.0128	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Cyclosporine—rheumatoid arthritis	0.0076	0.012	CcSEcCtD
Phenylpropanolamine—Anxiety—Penicillamine—rheumatoid arthritis	0.00743	0.0118	CcSEcCtD
Phenylpropanolamine—Constipation—Auranofin—rheumatoid arthritis	0.00662	0.0105	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisolone—rheumatoid arthritis	0.00594	0.00942	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Hydrocortisone—rheumatoid arthritis	0.0058	0.0092	CcSEcCtD
Phenylpropanolamine—Nausea—Ergocalciferol—rheumatoid arthritis	0.00564	0.00894	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Triamcinolone—rheumatoid arthritis	0.00546	0.00866	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Methylprednisolone—rheumatoid arthritis	0.00545	0.00864	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Penicillamine—rheumatoid arthritis	0.00527	0.00835	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Dexamethasone—rheumatoid arthritis	0.00496	0.00786	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Betamethasone—rheumatoid arthritis	0.00496	0.00786	CcSEcCtD
Phenylpropanolamine—Vomiting—Auranofin—rheumatoid arthritis	0.00492	0.0078	CcSEcCtD
Phenylpropanolamine—Rash—Auranofin—rheumatoid arthritis	0.00488	0.00773	CcSEcCtD
Phenylpropanolamine—Dermatitis—Auranofin—rheumatoid arthritis	0.00487	0.00773	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Hydrocortisone—rheumatoid arthritis	0.00479	0.00759	CcSEcCtD
Phenylpropanolamine—Irritability—Hydrocortisone—rheumatoid arthritis	0.00468	0.00742	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Azathioprine—rheumatoid arthritis	0.00468	0.00741	CcSEcCtD
Phenylpropanolamine—Nausea—Auranofin—rheumatoid arthritis	0.0046	0.00728	CcSEcCtD
Phenylpropanolamine—Vomiting—Penicillamine—rheumatoid arthritis	0.00454	0.0072	CcSEcCtD
Phenylpropanolamine—Rash—Penicillamine—rheumatoid arthritis	0.00451	0.00714	CcSEcCtD
Phenylpropanolamine—Dermatitis—Penicillamine—rheumatoid arthritis	0.0045	0.00714	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Methylprednisolone—rheumatoid arthritis	0.0045	0.00713	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Leflunomide—rheumatoid arthritis	0.00442	0.007	CcSEcCtD
Phenylpropanolamine—Irritability—Methylprednisolone—rheumatoid arthritis	0.0044	0.00697	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisone—rheumatoid arthritis	0.00432	0.00684	CcSEcCtD
Phenylpropanolamine—Nausea—Penicillamine—rheumatoid arthritis	0.00424	0.00673	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Betamethasone—rheumatoid arthritis	0.00409	0.00648	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Dexamethasone—rheumatoid arthritis	0.00409	0.00648	CcSEcCtD
Phenylpropanolamine—Vision blurred—Leflunomide—rheumatoid arthritis	0.00406	0.00643	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—TNF—rheumatoid arthritis	0.00401	0.0801	CrCbGaD
Phenylpropanolamine—Irritability—Dexamethasone—rheumatoid arthritis	0.004	0.00634	CcSEcCtD
Phenylpropanolamine—Irritability—Betamethasone—rheumatoid arthritis	0.004	0.00634	CcSEcCtD
Phenylpropanolamine—Anxiety—Leflunomide—rheumatoid arthritis	0.00365	0.00579	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Prednisone—rheumatoid arthritis	0.00356	0.00565	CcSEcCtD
Phenylpropanolamine—Flushing—Cyclosporine—rheumatoid arthritis	0.00354	0.00561	CcSEcCtD
Phenylpropanolamine—Irritability—Prednisone—rheumatoid arthritis	0.00348	0.00552	CcSEcCtD
Phenylpropanolamine—Hypotension—Azathioprine—rheumatoid arthritis	0.00348	0.00551	CcSEcCtD
Phenylpropanolamine—Tachycardia—Leflunomide—rheumatoid arthritis	0.00343	0.00543	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Cyclosporine—rheumatoid arthritis	0.00341	0.0054	CcSEcCtD
Phenylpropanolamine—Hallucination—Hydrocortisone—rheumatoid arthritis	0.00337	0.00535	CcSEcCtD
Phenylpropanolamine—Hypotension—Leflunomide—rheumatoid arthritis	0.00328	0.0052	CcSEcCtD
Phenylpropanolamine—Tension—Cyclosporine—rheumatoid arthritis	0.00326	0.00517	CcSEcCtD
Phenylpropanolamine—Nervousness—Cyclosporine—rheumatoid arthritis	0.00323	0.00511	CcSEcCtD
Phenylpropanolamine—Insomnia—Leflunomide—rheumatoid arthritis	0.00318	0.00504	CcSEcCtD
Phenylpropanolamine—Hallucination—Methylprednisolone—rheumatoid arthritis	0.00317	0.00503	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Leflunomide—rheumatoid arthritis	0.00313	0.00496	CcSEcCtD
Phenylpropanolamine—Vision blurred—Cyclosporine—rheumatoid arthritis	0.00313	0.00496	CcSEcCtD
Phenylpropanolamine—Tremor—Cyclosporine—rheumatoid arthritis	0.00311	0.00493	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisolone—rheumatoid arthritis	0.0031	0.00492	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Azathioprine—rheumatoid arthritis	0.00307	0.00486	CcSEcCtD
Phenylpropanolamine—Agitation—Cyclosporine—rheumatoid arthritis	0.00305	0.00484	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Hydrocortisone—rheumatoid arthritis	0.00303	0.0048	CcSEcCtD
Phenylpropanolamine—Constipation—Leflunomide—rheumatoid arthritis	0.003	0.00476	CcSEcCtD
Phenylpropanolamine—Irritability—Methotrexate—rheumatoid arthritis	0.00291	0.00461	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.0029	0.00459	CcSEcCtD
Phenylpropanolamine—Hallucination—Dexamethasone—rheumatoid arthritis	0.00288	0.00457	CcSEcCtD
Phenylpropanolamine—Hallucination—Betamethasone—rheumatoid arthritis	0.00288	0.00457	CcSEcCtD
Phenylpropanolamine—Ataxia—Methotrexate—rheumatoid arthritis	0.00287	0.00454	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Triamcinolone—rheumatoid arthritis	0.00285	0.00452	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisolone—rheumatoid arthritis	0.00285	0.00452	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Methylprednisolone—rheumatoid arthritis	0.00285	0.00451	CcSEcCtD
Phenylpropanolamine—Anxiety—Cyclosporine—rheumatoid arthritis	0.00282	0.00447	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Azathioprine—rheumatoid arthritis	0.00274	0.00434	CcSEcCtD
Phenylpropanolamine—Confusional state—Cyclosporine—rheumatoid arthritis	0.00273	0.00433	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Dexamethasone—rheumatoid arthritis	0.00259	0.0041	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Betamethasone—rheumatoid arthritis	0.00259	0.0041	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Leflunomide—rheumatoid arthritis	0.00259	0.0041	CcSEcCtD
Phenylpropanolamine—Hallucination—Prednisone—rheumatoid arthritis	0.00251	0.00398	CcSEcCtD
Phenylpropanolamine—Anxiety—Hydrocortisone—rheumatoid arthritis	0.0025	0.00397	CcSEcCtD
Phenylpropanolamine—Dizziness—Azathioprine—rheumatoid arthritis	0.00246	0.0039	CcSEcCtD
Phenylpropanolamine—Insomnia—Cyclosporine—rheumatoid arthritis	0.00245	0.00389	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Cyclosporine—rheumatoid arthritis	0.00242	0.00383	CcSEcCtD
Phenylpropanolamine—Somnolence—Cyclosporine—rheumatoid arthritis	0.00241	0.00382	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisolone—rheumatoid arthritis	0.00241	0.00382	CcSEcCtD
Phenylpropanolamine—Vomiting—Azathioprine—rheumatoid arthritis	0.00237	0.00375	CcSEcCtD
Phenylpropanolamine—Anxiety—Methylprednisolone—rheumatoid arthritis	0.00235	0.00373	CcSEcCtD
Phenylpropanolamine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.00235	0.00373	CcSEcCtD
Phenylpropanolamine—Drowsiness—Methotrexate—rheumatoid arthritis	0.00235	0.00372	CcSEcCtD
Phenylpropanolamine—Rash—Azathioprine—rheumatoid arthritis	0.00235	0.00372	CcSEcCtD
Phenylpropanolamine—Dermatitis—Azathioprine—rheumatoid arthritis	0.00234	0.00371	CcSEcCtD
Phenylpropanolamine—Flushing—Prednisone—rheumatoid arthritis	0.00234	0.00371	CcSEcCtD
Phenylpropanolamine—Dizziness—Leflunomide—rheumatoid arthritis	0.00232	0.00368	CcSEcCtD
Phenylpropanolamine—Constipation—Cyclosporine—rheumatoid arthritis	0.00232	0.00367	CcSEcCtD
Phenylpropanolamine—Confusional state—Methylprednisolone—rheumatoid arthritis	0.00228	0.00362	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisone—rheumatoid arthritis	0.00225	0.00357	CcSEcCtD
Phenylpropanolamine—Hypotension—Hydrocortisone—rheumatoid arthritis	0.00225	0.00357	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.00223	0.00354	CcSEcCtD
Phenylpropanolamine—Vomiting—Leflunomide—rheumatoid arthritis	0.00223	0.00354	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisolone—rheumatoid arthritis	0.00223	0.00354	CcSEcCtD
Phenylpropanolamine—Rash—Leflunomide—rheumatoid arthritis	0.00222	0.00351	CcSEcCtD
Phenylpropanolamine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.00221	0.00351	CcSEcCtD
Phenylpropanolamine—Dermatitis—Leflunomide—rheumatoid arthritis	0.00221	0.00351	CcSEcCtD
Phenylpropanolamine—Nausea—Azathioprine—rheumatoid arthritis	0.00221	0.0035	CcSEcCtD
Phenylpropanolamine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.00221	0.0035	CcSEcCtD
Phenylpropanolamine—Insomnia—Hydrocortisone—rheumatoid arthritis	0.00218	0.00345	CcSEcCtD
Phenylpropanolamine—Anxiety—Betamethasone—rheumatoid arthritis	0.00214	0.00339	CcSEcCtD
Phenylpropanolamine—Anxiety—Dexamethasone—rheumatoid arthritis	0.00214	0.00339	CcSEcCtD
Phenylpropanolamine—Hypotension—Methylprednisolone—rheumatoid arthritis	0.00212	0.00335	CcSEcCtD
Phenylpropanolamine—Nausea—Leflunomide—rheumatoid arthritis	0.00209	0.00331	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisone—rheumatoid arthritis	0.00207	0.00328	CcSEcCtD
Phenylpropanolamine—Insomnia—Triamcinolone—rheumatoid arthritis	0.00205	0.00325	CcSEcCtD
Phenylpropanolamine—Insomnia—Methylprednisolone—rheumatoid arthritis	0.00205	0.00325	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.00203	0.00322	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.00202	0.00321	CcSEcCtD
Phenylpropanolamine—Agitation—Prednisone—rheumatoid arthritis	0.00202	0.0032	CcSEcCtD
Phenylpropanolamine—Tachycardia—Betamethasone—rheumatoid arthritis	0.00201	0.00318	CcSEcCtD
Phenylpropanolamine—Tachycardia—Dexamethasone—rheumatoid arthritis	0.00201	0.00318	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.002	0.00317	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.00199	0.00315	CcSEcCtD
Phenylpropanolamine—Hypotension—Betamethasone—rheumatoid arthritis	0.00192	0.00305	CcSEcCtD
Phenylpropanolamine—Hypotension—Dexamethasone—rheumatoid arthritis	0.00192	0.00305	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.00187	0.00296	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.00187	0.00296	CcSEcCtD
Phenylpropanolamine—Anxiety—Prednisone—rheumatoid arthritis	0.00186	0.00295	CcSEcCtD
Phenylpropanolamine—Insomnia—Dexamethasone—rheumatoid arthritis	0.00186	0.00295	CcSEcCtD
Phenylpropanolamine—Insomnia—Betamethasone—rheumatoid arthritis	0.00186	0.00295	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.00182	0.00288	CcSEcCtD
Phenylpropanolamine—Dizziness—Cyclosporine—rheumatoid arthritis	0.00179	0.00284	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.00178	0.00281	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisone—rheumatoid arthritis	0.00175	0.00277	CcSEcCtD
Phenylpropanolamine—Vision blurred—Methotrexate—rheumatoid arthritis	0.00173	0.00274	CcSEcCtD
Phenylpropanolamine—Vomiting—Cyclosporine—rheumatoid arthritis	0.00172	0.00273	CcSEcCtD
Phenylpropanolamine—Rash—Cyclosporine—rheumatoid arthritis	0.00171	0.00271	CcSEcCtD
Phenylpropanolamine—Dermatitis—Cyclosporine—rheumatoid arthritis	0.00171	0.00271	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.0017	0.00269	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.0017	0.00269	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.00167	0.00265	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.00167	0.00264	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisolone—rheumatoid arthritis	0.00163	0.00259	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisone—rheumatoid arthritis	0.00162	0.00257	CcSEcCtD
Phenylpropanolamine—Nausea—Cyclosporine—rheumatoid arthritis	0.00161	0.00255	CcSEcCtD
Phenylpropanolamine—Dizziness—Hydrocortisone—rheumatoid arthritis	0.00159	0.00253	CcSEcCtD
Phenylpropanolamine—Rash—Prednisolone—rheumatoid arthritis	0.00156	0.00247	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisolone—rheumatoid arthritis	0.00155	0.00246	CcSEcCtD
Phenylpropanolamine—Constipation—Prednisone—rheumatoid arthritis	0.00153	0.00243	CcSEcCtD
Phenylpropanolamine—Vomiting—Hydrocortisone—rheumatoid arthritis	0.00153	0.00243	CcSEcCtD
Phenylpropanolamine—Rash—Hydrocortisone—rheumatoid arthritis	0.00152	0.00241	CcSEcCtD
Phenylpropanolamine—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.00152	0.00241	CcSEcCtD
Phenylpropanolamine—Confusional state—Methotrexate—rheumatoid arthritis	0.00151	0.00239	CcSEcCtD
Phenylpropanolamine—Dizziness—Triamcinolone—rheumatoid arthritis	0.0015	0.00238	CcSEcCtD
Phenylpropanolamine—Dizziness—Methylprednisolone—rheumatoid arthritis	0.0015	0.00237	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisone—rheumatoid arthritis	0.00148	0.00234	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisolone—rheumatoid arthritis	0.00147	0.00232	CcSEcCtD
Phenylpropanolamine—Vomiting—Triamcinolone—rheumatoid arthritis	0.00144	0.00229	CcSEcCtD
Phenylpropanolamine—Vomiting—Methylprednisolone—rheumatoid arthritis	0.00144	0.00228	CcSEcCtD
Phenylpropanolamine—Nausea—Hydrocortisone—rheumatoid arthritis	0.00143	0.00227	CcSEcCtD
Phenylpropanolamine—Rash—Triamcinolone—rheumatoid arthritis	0.00143	0.00227	CcSEcCtD
Phenylpropanolamine—Dermatitis—Triamcinolone—rheumatoid arthritis	0.00143	0.00227	CcSEcCtD
Phenylpropanolamine—Rash—Methylprednisolone—rheumatoid arthritis	0.00143	0.00226	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00143	0.00226	CcSEcCtD
Phenylpropanolamine—Hypotension—Methotrexate—rheumatoid arthritis	0.0014	0.00222	CcSEcCtD
Phenylpropanolamine—Dizziness—Betamethasone—rheumatoid arthritis	0.00136	0.00216	CcSEcCtD
Phenylpropanolamine—Dizziness—Dexamethasone—rheumatoid arthritis	0.00136	0.00216	CcSEcCtD
Phenylpropanolamine—Insomnia—Methotrexate—rheumatoid arthritis	0.00136	0.00215	CcSEcCtD
Phenylpropanolamine—Nausea—Triamcinolone—rheumatoid arthritis	0.00135	0.00214	CcSEcCtD
Phenylpropanolamine—Nausea—Methylprednisolone—rheumatoid arthritis	0.00134	0.00213	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Methotrexate—rheumatoid arthritis	0.00134	0.00212	CcSEcCtD
Phenylpropanolamine—Somnolence—Methotrexate—rheumatoid arthritis	0.00133	0.00211	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisone—rheumatoid arthritis	0.00132	0.00209	CcSEcCtD
Phenylpropanolamine—Vomiting—Dexamethasone—rheumatoid arthritis	0.00131	0.00207	CcSEcCtD
Phenylpropanolamine—Vomiting—Betamethasone—rheumatoid arthritis	0.00131	0.00207	CcSEcCtD
Phenylpropanolamine—Rash—Dexamethasone—rheumatoid arthritis	0.0013	0.00206	CcSEcCtD
Phenylpropanolamine—Rash—Betamethasone—rheumatoid arthritis	0.0013	0.00206	CcSEcCtD
Phenylpropanolamine—Dermatitis—Betamethasone—rheumatoid arthritis	0.0013	0.00206	CcSEcCtD
Phenylpropanolamine—Dermatitis—Dexamethasone—rheumatoid arthritis	0.0013	0.00206	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.00123	0.00196	CcSEcCtD
Phenylpropanolamine—Nausea—Betamethasone—rheumatoid arthritis	0.00122	0.00194	CcSEcCtD
Phenylpropanolamine—Nausea—Dexamethasone—rheumatoid arthritis	0.00122	0.00194	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisone—rheumatoid arthritis	0.00119	0.00188	CcSEcCtD
Phenylpropanolamine—Vomiting—Prednisone—rheumatoid arthritis	0.00114	0.00181	CcSEcCtD
Phenylpropanolamine—Rash—Prednisone—rheumatoid arthritis	0.00113	0.00179	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisone—rheumatoid arthritis	0.00113	0.00179	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.0011	0.00175	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisone—rheumatoid arthritis	0.00106	0.00169	CcSEcCtD
Phenylpropanolamine—Dizziness—Methotrexate—rheumatoid arthritis	0.000991	0.00157	CcSEcCtD
Phenylpropanolamine—Vomiting—Methotrexate—rheumatoid arthritis	0.000953	0.00151	CcSEcCtD
Phenylpropanolamine—Rash—Methotrexate—rheumatoid arthritis	0.000945	0.0015	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methotrexate—rheumatoid arthritis	0.000944	0.0015	CcSEcCtD
Phenylpropanolamine—Nausea—Methotrexate—rheumatoid arthritis	0.00089	0.00141	CcSEcCtD
Phenylpropanolamine—ADRB1—Signaling Pathways—RASGRP1—rheumatoid arthritis	9.89e-05	0.00031	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SAA1—rheumatoid arthritis	9.87e-05	0.000309	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SYK—rheumatoid arthritis	9.86e-05	0.000309	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL2RA—rheumatoid arthritis	9.81e-05	0.000308	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—C3—rheumatoid arthritis	9.73e-05	0.000305	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TRAF6—rheumatoid arthritis	9.72e-05	0.000305	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SH2B3—rheumatoid arthritis	9.72e-05	0.000305	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PRKCQ—rheumatoid arthritis	9.68e-05	0.000303	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RASGRP1—rheumatoid arthritis	9.68e-05	0.000303	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NCF1—rheumatoid arthritis	9.67e-05	0.000303	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—GZMB—rheumatoid arthritis	9.66e-05	0.000303	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SYK—rheumatoid arthritis	9.65e-05	0.000302	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—POMC—rheumatoid arthritis	9.62e-05	0.000302	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—MTHFR—rheumatoid arthritis	9.56e-05	0.0003	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP3—rheumatoid arthritis	9.51e-05	0.000298	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—STAT1—rheumatoid arthritis	9.51e-05	0.000298	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—TYK2—rheumatoid arthritis	9.51e-05	0.000298	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PRKCQ—rheumatoid arthritis	9.47e-05	0.000297	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CCL2—rheumatoid arthritis	9.41e-05	0.000295	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—POMC—rheumatoid arthritis	9.41e-05	0.000295	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6R—rheumatoid arthritis	9.38e-05	0.000294	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL3—rheumatoid arthritis	9.38e-05	0.000294	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL2—rheumatoid arthritis	9.38e-05	0.000294	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL10—rheumatoid arthritis	9.37e-05	0.000294	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MED1—rheumatoid arthritis	9.35e-05	0.000293	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—IL2—rheumatoid arthritis	9.31e-05	0.000292	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—STAT1—rheumatoid arthritis	9.3e-05	0.000292	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CD28—rheumatoid arthritis	9.3e-05	0.000291	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCR5—rheumatoid arthritis	9.25e-05	0.00029	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CCL2—rheumatoid arthritis	9.21e-05	0.000289	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6R—rheumatoid arthritis	9.18e-05	0.000288	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SAA1—rheumatoid arthritis	9.17e-05	0.000288	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL10—rheumatoid arthritis	9.17e-05	0.000287	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PTK2—rheumatoid arthritis	9.15e-05	0.000287	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL2RA—rheumatoid arthritis	9.12e-05	0.000286	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	9.11e-05	0.000286	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—C3—rheumatoid arthritis	9.04e-05	0.000283	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NCF1—rheumatoid arthritis	8.98e-05	0.000282	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL5—rheumatoid arthritis	8.98e-05	0.000281	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CSF2—rheumatoid arthritis	8.84e-05	0.000277	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.75e-05	0.000274	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—IL2—rheumatoid arthritis	8.71e-05	0.000273	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	8.69e-05	0.000272	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	8.69e-05	0.000272	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CD28—rheumatoid arthritis	8.64e-05	0.000271	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—BDKRB2—rheumatoid arthritis	8.58e-05	0.000269	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL12—rheumatoid arthritis	8.58e-05	0.000269	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—POMC—rheumatoid arthritis	8.57e-05	0.000269	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP3—rheumatoid arthritis	8.55e-05	0.000268	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—TYK2—rheumatoid arthritis	8.55e-05	0.000268	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6ST—rheumatoid arthritis	8.51e-05	0.000267	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADRBK1—rheumatoid arthritis	8.49e-05	0.000266	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP3—rheumatoid arthritis	8.36e-05	0.000262	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—TYK2—rheumatoid arthritis	8.36e-05	0.000262	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SPP1—rheumatoid arthritis	8.31e-05	0.000261	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL8—rheumatoid arthritis	8.28e-05	0.000259	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTK2—rheumatoid arthritis	8.23e-05	0.000258	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	8.19e-05	0.000257	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—UBE2D1—rheumatoid arthritis	8.13e-05	0.000255	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCR5—rheumatoid arthritis	8.09e-05	0.000254	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL5—rheumatoid arthritis	8.07e-05	0.000253	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTK2—rheumatoid arthritis	8.05e-05	0.000252	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	8.01e-05	0.000251	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RASGRP1—rheumatoid arthritis	8e-05	0.000251	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SYK—rheumatoid arthritis	7.98e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL12—rheumatoid arthritis	7.97e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—BDKRB2—rheumatoid arthritis	7.97e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL2RA—rheumatoid arthritis	7.97e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—POMC—rheumatoid arthritis	7.96e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CSF2—rheumatoid arthritis	7.95e-05	0.000249	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—VEGFA—rheumatoid arthritis	7.92e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL2—rheumatoid arthritis	7.91e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	7.91e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—C3—rheumatoid arthritis	7.9e-05	0.000248	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL5—rheumatoid arthritis	7.89e-05	0.000247	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	7.88e-05	0.000247	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.83e-05	0.000246	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—IL2—rheumatoid arthritis	7.83e-05	0.000245	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—BGN—rheumatoid arthritis	7.82e-05	0.000245	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—POMC—rheumatoid arthritis	7.78e-05	0.000244	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CSF2—rheumatoid arthritis	7.78e-05	0.000244	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—STAT1—rheumatoid arthritis	7.69e-05	0.000241	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—IL2—rheumatoid arthritis	7.66e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CAT—rheumatoid arthritis	7.65e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—POMC—rheumatoid arthritis	7.65e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL2—rheumatoid arthritis	7.61e-05	0.000239	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6R—rheumatoid arthritis	7.59e-05	0.000238	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL10—rheumatoid arthritis	7.58e-05	0.000238	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SPP1—rheumatoid arthritis	7.47e-05	0.000234	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.44e-05	0.000233	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	7.44e-05	0.000233	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SYK—rheumatoid arthritis	7.41e-05	0.000232	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—LEP—rheumatoid arthritis	7.36e-05	0.000231	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SPP1—rheumatoid arthritis	7.31e-05	0.000229	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—rheumatoid arthritis	7.28e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	7.28e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCR5—rheumatoid arthritis	7.27e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TGFB1—rheumatoid arthritis	7.27e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—POMC—rheumatoid arthritis	7.23e-05	0.000227	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	7.2e-05	0.000226	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL2RA—rheumatoid arthritis	7.16e-05	0.000225	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—STAT1—rheumatoid arthritis	7.15e-05	0.000224	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCR5—rheumatoid arthritis	7.11e-05	0.000223	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL2—rheumatoid arthritis	7.11e-05	0.000223	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—C3—rheumatoid arthritis	7.1e-05	0.000223	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	7.07e-05	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	7.05e-05	0.000221	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	7.05e-05	0.000221	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL2RA—rheumatoid arthritis	7.01e-05	0.00022	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ALB—rheumatoid arthritis	6.97e-05	0.000219	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL2—rheumatoid arthritis	6.96e-05	0.000218	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—C3—rheumatoid arthritis	6.95e-05	0.000218	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FN1—rheumatoid arthritis	6.94e-05	0.000218	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP3—rheumatoid arthritis	6.92e-05	0.000217	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TYK2—rheumatoid arthritis	6.91e-05	0.000217	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6ST—rheumatoid arthritis	6.91e-05	0.000217	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—NOS3—rheumatoid arthritis	6.67e-05	0.000209	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTK2—rheumatoid arthritis	6.66e-05	0.000209	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CD80—rheumatoid arthritis	6.65e-05	0.000209	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.63e-05	0.000208	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—LEP—rheumatoid arthritis	6.61e-05	0.000207	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL5—rheumatoid arthritis	6.53e-05	0.000205	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—LEP—rheumatoid arthritis	6.47e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CSF2—rheumatoid arthritis	6.43e-05	0.000202	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	6.43e-05	0.000202	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	6.42e-05	0.000201	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	6.39e-05	0.0002	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—IL2—rheumatoid arthritis	6.34e-05	0.000199	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.33e-05	0.000199	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—POMC—rheumatoid arthritis	6.32e-05	0.000198	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FN1—rheumatoid arthritis	6.24e-05	0.000196	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6ST—rheumatoid arthritis	6.21e-05	0.000195	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	6.19e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL2—rheumatoid arthritis	6.18e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6R—rheumatoid arthritis	6.17e-05	0.000193	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	6.16e-05	0.000193	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FN1—rheumatoid arthritis	6.1e-05	0.000191	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—rheumatoid arthritis	6.1e-05	0.000191	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6ST—rheumatoid arthritis	6.08e-05	0.000191	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	6.07e-05	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	6.05e-05	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	6.02e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	5.98e-05	0.000188	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CD80—rheumatoid arthritis	5.98e-05	0.000187	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	5.98e-05	0.000187	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	5.89e-05	0.000185	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	5.88e-05	0.000184	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	5.87e-05	0.000184	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CD80—rheumatoid arthritis	5.85e-05	0.000183	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	5.8e-05	0.000182	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.77e-05	0.000181	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	5.75e-05	0.00018	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	5.75e-05	0.00018	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—POMC—rheumatoid arthritis	5.68e-05	0.000178	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	5.62e-05	0.000176	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TYK2—rheumatoid arthritis	5.62e-05	0.000176	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.59e-05	0.000175	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL2—rheumatoid arthritis	5.56e-05	0.000174	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—POMC—rheumatoid arthritis	5.56e-05	0.000174	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6R—rheumatoid arthritis	5.54e-05	0.000174	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOS3—rheumatoid arthritis	5.51e-05	0.000173	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	5.47e-05	0.000171	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL2—rheumatoid arthritis	5.44e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6R—rheumatoid arthritis	5.42e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	5.39e-05	0.000169	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	5.35e-05	0.000168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	5.35e-05	0.000168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	5.34e-05	0.000167	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—POMC—rheumatoid arthritis	5.11e-05	0.00016	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.05e-05	0.000158	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TYK2—rheumatoid arthritis	5.05e-05	0.000158	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	5.05e-05	0.000158	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.03e-05	0.000158	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	4.97e-05	0.000156	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOS3—rheumatoid arthritis	4.96e-05	0.000155	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TYK2—rheumatoid arthritis	4.94e-05	0.000155	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.89e-05	0.000153	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOS3—rheumatoid arthritis	4.85e-05	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	4.84e-05	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	4.69e-05	0.000147	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	4.67e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.67e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALB—rheumatoid arthritis	4.66e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	4.65e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	4.6e-05	0.000144	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	4.5e-05	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	4.5e-05	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	4.48e-05	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	4.45e-05	0.00014	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	4.42e-05	0.000139	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—rheumatoid arthritis	4.4e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	4.38e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	4.3e-05	0.000135	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—rheumatoid arthritis	4.3e-05	0.000135	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	4.27e-05	0.000134	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	4.22e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL2—rheumatoid arthritis	4.2e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—rheumatoid arthritis	4.18e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	4.18e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	4.17e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL2—rheumatoid arthritis	4.11e-05	0.000129	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—rheumatoid arthritis	4.09e-05	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	4.08e-05	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	4.07e-05	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	4.01e-05	0.000126	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—rheumatoid arthritis	3.98e-05	0.000125	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.97e-05	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NFKB1—rheumatoid arthritis	3.93e-05	0.000123	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—rheumatoid arthritis	3.89e-05	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAPK8—rheumatoid arthritis	3.87e-05	0.000121	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NFKB1—rheumatoid arthritis	3.85e-05	0.000121	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	3.8e-05	0.000119	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.78e-05	0.000119	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	3.73e-05	0.000117	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.64e-05	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—VEGFA—rheumatoid arthritis	3.57e-05	0.000112	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.56e-05	0.000111	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	3.53e-05	0.000111	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—VEGFA—rheumatoid arthritis	3.49e-05	0.000109	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	3.4e-05	0.000107	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	3.38e-05	0.000106	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.3e-05	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.28e-05	0.000103	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	3.22e-05	0.000101	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFB1—rheumatoid arthritis	3.21e-05	0.0001	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.18e-05	9.98e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	3.16e-05	9.9e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.14e-05	9.85e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.13e-05	9.81e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	3e-05	9.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	2.99e-05	9.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.96e-05	9.27e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.91e-05	9.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.89e-05	9.06e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	2.82e-05	8.84e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	2.75e-05	8.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TP53—rheumatoid arthritis	2.7e-05	8.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.68e-05	8.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.65e-05	8.31e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TP53—rheumatoid arthritis	2.64e-05	8.27e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	2.57e-05	8.06e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—rheumatoid arthritis	2.47e-05	7.74e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.46e-05	7.72e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	2.46e-05	7.71e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—rheumatoid arthritis	2.42e-05	7.57e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.25e-05	7.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	2.18e-05	6.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	2.03e-05	6.36e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	2e-05	6.26e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	1.86e-05	5.82e-05	CbGpPWpGaD
